Columns: 1: chrom, 2: pos, 3: ref, 4: alt, 5: start, 6: stop, 7: strand, 8: variation_type, 9: variation_id, 10: rcv, 11: scv, 12: allele_id, 13: symbol, 14: hgvs_c, 15: hgvs_p, 16: molecular_consequence, 17: clinical_significance, 18: clinical_significance_ordered, 19: pathogenic, 20: likely_pathogenic, 21: uncertain_significance, 22: likely_benign, 23: benign, 24: review_status, 25: review_status_ordered, 26: last_evaluated, 27: all_submitters, 28: submitters_ordered, 29: all_traits, 30: all_pmids, 31: inheritance_modes, 32: age_of_onset, 33: prevalence, 34: disease_mechanism, 35: origin, 36: xrefs, 37: dates_ordered, 38: gold_stars, 39: conflicted,
================
Total rows: 287576
================
column 8: variation_type
Variant      287575
Haplotype         1
Name: variation_type, dtype: int64
================
column 17: clinical_significance
Uncertain significance                                                             116232
Likely benign                                                                       50987
Pathogenic                                                                          43393
Benign                                                                              23439
Likely pathogenic                                                                   14038
Conflicting interpretations of pathogenicity                                        12024
not provided                                                                        10697
Benign/Likely benign                                                                10575
Pathogenic/Likely pathogenic                                                         2890
other                                                                                1791
risk factor                                                                           394
drug response                                                                         280
association                                                                           127
Affects                                                                                95
Pathogenic, other                                                                      88
Pathogenic, risk factor                                                                74
Conflicting interpretations of pathogenicity, risk factor                              44
Benign, risk factor                                                                    27
protective                                                                             26
Pathogenic, drug response                                                              26
Likely pathogenic, risk factor                                                         24
Likely benign, risk factor                                                             23
Benign/Likely benign, risk factor                                                      22
Benign, other                                                                          22
Conflicting interpretations of pathogenicity, not provided                             21
Pathogenic/Likely pathogenic, risk factor                                              19
Uncertain significance, risk factor                                                    18
Uncertain significance, drug response                                                  16
Conflicting interpretations of pathogenicity, other                                    13
Benign/Likely benign, not provided                                                     11
                                                                                    ...  
protective, risk factor                                                                 2
Conflicting interpretations of pathogenicity, Affects, association, risk factor         2
Likely pathogenic, association                                                          2
Conflicting interpretations of pathogenicity, Affects                                   2
Conflicting interpretations of pathogenicity, protective                                2
Conflicting interpretations of pathogenicity, association                               2
Conflicting interpretations of pathogenicity, association, other, risk factor           1
Uncertain significance, association                                                     1
Pathogenic, association, protective                                                     1
Benign/Likely benign, protective, risk factor                                           1
Benign, drug response                                                                   1
Benign, association, protective                                                         1
Conflicting interpretations of pathogenicity, association, risk factor                  1
Likely benign, drug response                                                            1
Likely pathogenic, Affects                                                              1
Conflicting interpretations of pathogenicity, Affects, association                      1
Pathogenic/Likely pathogenic, Affects, risk factor                                      1
Benign, drug response, risk factor                                                      1
Likely benign, Affects                                                                  1
Conflicting interpretations of pathogenicity, other, risk factor                        1
Benign/Likely benign, drug response, risk factor                                        1
Benign, association, risk factor                                                        1
Uncertain significance, Affects                                                         1
Uncertain significance, protective                                                      1
Benign/Likely benign, drug response                                                     1
Conflicting interpretations of pathogenicity, Affects, other                            1
Benign, protective, risk factor                                                         1
Pathogenic, protective, risk factor                                                     1
Benign, Affects                                                                         1
Affects, risk factor                                                                    1
Name: clinical_significance, dtype: int64
================
column 24: review_status
criteria provided, single submitter                     190348
criteria provided, multiple submitters, no conflicts     33311
no assertion criteria provided                           32493
criteria provided, conflicting interpretations           11998
no assertion provided                                    10690
reviewed by expert panel                                  8602
no assertion for the individual variant                    109
practice guideline                                          23
-                                                            2
Name: review_status, dtype: int64
================
column 38: gold_stars
1    181471
0     38074
2     29669
1     20875
3      5594
0      5218
2      3642
3      3008
4        23
-         2
Name: gold_stars, dtype: int64
================
column 27: all_submitters
Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   75372
GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           37884
Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          19648
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            14832
OMIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             14310
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       8889
Ambry Genetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    8106
PreventionGenetics,PreventionGenetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             4973
Genetic Services Laboratory, University of Chicago                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                4584
GeneReviews                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       2343
Counsyl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2211
PreventionGenetics,PreventionGenetics;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1972
GeneDx;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1830
Ambry Genetics;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1584
ITMI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1495
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 1472
Illumina Clinical Services Laboratory,Illumina;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1433
Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1299
Invitae;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1291
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1265
InSiGHT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1208
Tuberous sclerosis database (TSC2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1190
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1180
Retina International                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1057
Systems Biology Platform Zhejiang California International NanoSystems Institute                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1005
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 991
Praxis fuer Humangenetik Tuebingen,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                967
Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)                                                                                                                                                                                                                                                                                                                                                                                                                         947
GeneReviews;OMIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   945
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        941
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 ...  
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Diagnostic Laboratory,Strasbourg University Hospital;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
Biesecker Lab/Human Development Section,National Institutes of Health;Invitae;Breast Cancer Information Core (BIC) (BRCA2);Sharing Clinical Reports Project (SCRP);Ambry Genetics                                                                                                                                                                                                                                                                                                                                                                                                                    1
GeneDx;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Genetic Services Laboratory, University of Chicago;Illumina Clinical Services Laboratory,Illumina;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                               1
Blueprint Genetics;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;GeneDx;Illumina Clinical Services Laboratory,Illumina;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                         1
GeneDx;Genetic Services Laboratory, University of Chicago;Ambry Genetics;Invitae;Counsyl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1
LDLR-LOVD, British Heart Foundation;Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital;OMIM;Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation;Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix;Robarts Research Institute,University of Western Ontario;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille;Dept. of Genetics and Pharmacogenomics, Merck Research Labs        1
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;Genetics Diagnostic Laboratory,Children's Hospital of Eastern Ontario;Blueprint Genetics;Illumina Clinical Services Laboratory,Illumina;Invitae;Ambry Genetics                                                                                                                                                                                                                                                                                                                                                           1
Illumina Clinical Services Laboratory,Illumina;Invitae;ITMI;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Sharing Clinical Reports Project (SCRP);Quest Diagnostics Nichols Institute San Juan Capistrano,;GeneDx                                                                                                                                                                                                                                                                                                                   1
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Molecular Diagnostics Lab,Nemours Alfred I. duPont Hospital for Children;Genetic Services Laboratory, University of Chicago                                                                                                                                                                                                                                                                                                                                                                                                                    1
Laboratory Corporation of America,;GeneDx;Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1
Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix;Robarts Research Institute,University of Western Ontario                                                                                                                                                                                                                                                                                                                                                                    1
PreventionGenetics,PreventionGenetics;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;Counsyl;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                  1
GeneReviews;Genetic Services Laboratory, University of Chicago;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics                                                                                                                                                                                                                                                                                                                                                                                              1
Invitae ;Laboratory Corporation of America,;Counsyl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1
TilsonLab,Columbia University                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1
Laboratory Corporation of America,;Quest Diagnostics Nichols Institute San Juan Capistrano,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1
OMIM;University of Washington Department of Laboratory Medicine,University of Washington;InSiGHT;Ambry Genetics;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1
GeneDx;Knight Diagnostic Laboratories,Oregon Health and Sciences University;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1
Epithelial Biology,  Institute of Medical Biology, Singapore;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics                                                                                                                                                                                                                                                                                                                                                                                                       1
Invitae ;GeneDx;Breast Cancer Information Core (BIC) (BRCA1);Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Quest Diagnostics Nichols Institute San Juan Capistrano,;Sharing Clinical Reports Project (SCRP);GeneKor MSA                                                                                                                                                                                                                                                 1
UniProtKB/Swiss-Prot;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Invitae;Illumina Clinical Services Laboratory,Illumina;Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics                                                                                                                                                                                                                                                                                                                                                                                 1
InSiGHT;Illumina Clinical Services Laboratory,Illumina;Invitae;GeneDx;Ambry Genetics;Counsyl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1
Invitae;Ambry Genetics;Illumina Clinical Services Laboratory,Illumina;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1
ITMI;Genetic Services Laboratory, University of Chicago;Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                          1
Invitae ;Division of Human Genetics Innsbruck,Medical University Innsbruck;Quest Diagnostics Nichols Institute San Juan Capistrano,;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Breast Cancer Information Core (BIC) (BRCA1);Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Michigan Medical Genetics Laboratories,University of Michigan                                                                                                                                                                            1
PALB2 database;Invitae;Counsyl;Cancer Genetics Laboratory,Peter MacCallum Cancer Centre;Ambry Genetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1
SNPedia;LDLR-LOVD, British Heart Foundation;Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1
Laboratory Corporation of America,;InSiGHT;Ambry Genetics;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
Genetic Services Laboratory, University of Chicago;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Invitae                                                                                                                                                                                                                                                                                                                                                                                                  1
Name: all_submitters, dtype: int64
================
column 31: inheritance_modes
Autosomal dominant inheritance                                                                                                59357
Autosomal recessive inheritance                                                                                               24287
Autosomal dominant inheritance;Autosomal recessive inheritance                                                                 2761
X-linked inheritance                                                                                                           2356
Autosomal dominant inheritance;Somatic mutation                                                                                1348
Autosomal recessive inheritance;Autosomal dominant inheritance                                                                  921
X-linked dominant inheritance;X-linked inheritance                                                                              517
X-linked recessive inheritance                                                                                                  487
Autosomal recessive inheritance;Mitochondrial inheritance                                                                       320
Autosomal dominant inheritance;Sporadic                                                                                         313
Somatic mutation                                                                                                                286
Autosomal dominant inheritance;Autosomal recessive inheritance;Other                                                            220
Autosomal dominant inheritance;Autosomal recessive inheritance;Sporadic                                                         217
Sporadic                                                                                                                        193
Autosomal recessive inheritance;X-linked inheritance;X-linked recessive inheritance                                             188
Autosomal recessive inheritance;X-linked inheritance                                                                            115
Autosomal recessive inheritance;Codominant                                                                                      102
X-linked inheritance;X-linked recessive inheritance                                                                              99
Autosomal dominant inheritance;Autosomal unknown;Autosomal recessive inheritance                                                 91
Somatic mutation;Autosomal dominant inheritance                                                                                  91
Mitochondrial inheritance                                                                                                        78
Autosomal dominant inheritance;X-linked dominant inheritance                                                                     75
Sporadic;Autosomal recessive inheritance;Autosomal dominant inheritance                                                          62
Autosomal recessive inheritance;Autosomal dominant inheritance;Sporadic                                                          58
Autosomal dominant inheritance;Sporadic;Autosomal recessive inheritance                                                          55
Sporadic;Autosomal dominant inheritance;Autosomal recessive inheritance                                                          52
Autosomal recessive inheritance;Sporadic;Autosomal dominant inheritance                                                          49
Autosomal dominant inheritance;X-linked inheritance                                                                              47
Autosomal dominant inheritance;Autosomal recessive inheritance;Sporadic;X-linked dominant inheritance;X-linked inheritance       32
Autosomal recessive inheritance;Autosomal dominant inheritance;Autosomal unknown                                                 29
X-linked dominant inheritance                                                                                                    26
Autosomal unknown                                                                                                                25
X-linked inheritance;Autosomal recessive inheritance                                                                             19
Sex-limited autosomal dominant;Autosomal recessive inheritance                                                                   18
X-linked dominant inheritance;X-linked recessive inheritance                                                                     17
Autosomal recessive inheritance;Sex-limited autosomal dominant                                                                   16
X-linked dominant inheritance;X-linked inheritance;Autosomal dominant inheritance;Autosomal recessive inheritance;Sporadic       16
Autosomal dominant inheritance;Autosomal unknown                                                                                 14
Sex-limited autosomal dominant                                                                                                   13
Sporadic;Autosomal dominant inheritance                                                                                           9
Autosomal dominant inheritance;Autosomal recessive inheritance;Autosomal unknown                                                  8
Other                                                                                                                             7
Somatic mutation;Autosomal dominant inheritance;Autosomal recessive inheritance                                                   4
Autosomal dominant inheritance;Autosomal recessive inheritance;Somatic mutation                                                   4
Autosomal dominant inheritance;Somatic mutation;Autosomal recessive inheritance                                                   4
X-linked inheritance;Autosomal recessive inheritance;X-linked recessive inheritance                                               3
X-linked recessive inheritance;Autosomal dominant inheritance                                                                     2
Autosomal recessive inheritance;Autosomal dominant inheritance;X-linked inheritance                                               1
Autosomal dominant inheritance;X-linked inheritance;Autosomal recessive inheritance                                               1
Autosomal dominant inheritance;Autosomal unknown;Somatic mutation                                                                 1
Autosomal dominant inheritance;Autosomal recessive inheritance;Mitochondrial inheritance                                          1
Autosomal dominant inheritance;Mitochondrial inheritance                                                                          1
Somatic mutation;Autosomal dominant inheritance;Autosomal unknown                                                                 1
Somatic mutation;Sporadic;Autosomal dominant inheritance                                                                          1
Autosomal recessive inheritance;X-linked inheritance;X-linked recessive inheritance;Autosomal dominant inheritance                1
Sporadic;Somatic mutation;Autosomal dominant inheritance                                                                          1
Autosomal recessive inheritance;Codominant;X-linked inheritance;X-linked recessive inheritance                                    1
Name: inheritance_modes, dtype: int64
================
column 32: age_of_onset
Infancy                                        22010
All ages                                       21923
Childhood                                      16093
Adult                                           7835
Adolescent                                      7642
Antenatal                                       6830
Neonatal                                        5697
Adolescent;All ages                             1856
Neonatal/infancy                                 627
Adult;Childhood                                  318
Adolescent;Childhood                             317
Infancy;Neonatal;Neonatal/infancy                309
Childhood;Adult                                  295
Childhood;Infancy                                288
Infancy;Childhood                                255
Adolescent;Infancy                               230
All ages;Childhood                               210
Infancy;Neonatal                                 188
Neonatal;Infancy                                 187
Childhood;Adolescent                             171
All ages;Neonatal                                146
Adult;All ages                                   139
Childhood;Adult;Adolescent;All ages              129
Infancy;Adolescent                               122
All ages;Adult                                   118
Adult;Infancy                                    115
Adolescent;All ages;Childhood;Adult              113
Adult;Childhood;Adolescent;All ages              109
All ages;Childhood;Neonatal                      105
Childhood;All ages                               103
                                               ...  
Neonatal;Adolescent                                1
Adolescent;Variable;Childhood                      1
Neonatal;Childhood;Infancy;Antenatal               1
Childhood;All ages;Adolescent;Adult                1
All ages;Childhood;Antenatal                       1
Adolescent;Adult;Childhood;Infancy                 1
All ages;Infancy;Adolescent;Adult                  1
Antenatal;Adolescent;Neonatal/infancy              1
Antenatal;Infancy;All ages;Adult                   1
Adult;Adolescent;All ages;Childhood                1
Adult;Childhood;Infancy                            1
Infancy;Childhood;Neonatal;Neonatal/infancy        1
Neonatal;All ages;Childhood                        1
Infancy;All ages;Childhood;Antenatal               1
Childhood;Neonatal;Variable;All ages;Adult         1
Adult;Neonatal                                     1
Infancy;Adult;All ages                             1
Adolescent;Infancy;All ages;Adult                  1
Childhood;Adolescent;All ages;Adult                1
Childhood;All ages;Adolescent                      1
Antenatal;Adult;Infancy;All ages                   1
Antenatal;Childhood;Infancy;Neonatal               1
Childhood;Infancy;Antenatal;Neonatal               1
Adolescent;Childhood;Adult;All ages                1
Adult;Infancy;Childhood;Variable;All ages          1
Adult;All ages;Adolescent                          1
Childhood;Adult;Infancy                            1
Adult;Neonatal/infancy;Infancy                     1
Childhood;Infancy;Adolescent                       1
Adolescent;Adult;Childhood                         1
Name: age_of_onset, dtype: int64
================
column 33: prevalence
<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              24324
1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               18145
1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             14436
1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               6618
1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 6239
1-9 / 100 000;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 2148
http://www.ncbi.nlm.nih.gov/books/NBK1247/;1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1231
1 in 2000-4000 depending on the population studied.;1-9 / 100 000;1:3200                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1193
2.29 to 3.2 per 100,000 individuals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1096
http://www.ncbi.nlm.nih.gov/books/NBK1247/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1029
1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.;http://www.ncbi.nlm.nih.gov/books/NBK1247/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1017
1-5 / 10 000;1:3,000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          922
1-9 / 1 000 000;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                579
>1 / 1000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     476
1-9 / 100 000;Prevalence in Finland is at least 9:100,000 individuals.;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         394
<1 / 1 000 000;1-9 / 100 000;Prevalence in Finland is at least 9:100,000 individuals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         387
<1 / 1 000 000;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  328
1-9 / 100 000;Rett syndrome is an X linked condition that occurs in 1 in 10,000 to 1 in 15,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   301
1-9 / 100 000;CHARGE syndrome is an autosomal dominant condition that occurs in 1 in 12,000 live births.;CHARGE syndrome occurs in at least one in 10,000 births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             292
1-9 / 100 000;CdLS occurs in 1 in 10-100,000 live births.;Cornelia de Lange syndrome occurs in 1 in 10-100,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   278
1-5 / 10 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  253
<1 / 1 000 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                252
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            251
1/15 000;1:15,000;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              233
1-9 / 100 000;Wilson disease is an autosomal recessive disorder with a prevalence of 1/30,000, and a carrier frequency of 1/90.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               233
1-9 / 1 000 000;Hennekam et al [1990b] reported a birth prevalence of 1:100,000 to 1:125,000 for RSTS in the Netherlands.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     231
1 per million;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  225
1-9 / 100 000;<1 / 1 000 000;Prevalence in Finland is at least 9:100,000 individuals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         207
1-9 / 100 000;Sotos syndrome is an autosomal dominant condition that occurs in 1 in 14,000 live births.;Sotos syndrome occurs in 1 in 14,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     204
1 in 5,000 male live births;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     201
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ...  
1-5 / 10 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-5 / 10 000;males affected with fragile X syndrome: 16 to 25:100,000  females affected with fragile X syndrome: approximately one-half the males prevalence  Unaffected female FMR1 carriers: 1:113 to 1:259  Females with FMR1-related POF: 4%-6% of all cases of 46,XX,POI  FXTAS males: an estimated 2%-4% of men with adult-onset cerebellar ataxia who represent simplex cases have a premutation in FMR1.;males affected with fragile X syndrome: 1:2,564 to 1:6,250  females affected with fragile X syndrome: approximately one-half the males prevalence  Unaffected female FMR1 carriers: 1:113 to 1:382  Females with FMR1-related POF: 1:7 (1:15 for the general population)                                                                                                                                                                                                                                                                                                                       1
<1 / 1 000 000;1-9 / 100 000;1-5 / 10 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
<1 / 1 000 000;The estimated incidence of permanent neonatal diabetes ranges from 1:215,000 to 1:260,000 live births                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1
1-5 / 10 000;http://www.ncbi.nlm.nih.gov/books/NBK1247/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1
<1 / 1 000 000;1-9 / 1 000 000;Estimates range from 1:250,000 to 1:50,000.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1
Gastric cancer is the 4th most frequently diagnosed cancer and the 2nd leading cause of death from cancer, with an estimated 990000 new cases and 738000 deaths registered.;<1 / 1 000 000;1-9 / 1 000 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
20210G>A heterozygosity occurs in 1.7%-3% of the general US and European populations: in the US, the prevalence of 20210G>A heterozygosity is 2%-5% in whites and 0%-0.3% in African Americans: among adults with VTE, 20210G>A heterozygosity is present in 6%-14% of those with a first VTE, and 18%-21% of those with a personal or family history of recurrent VTE: the prevalence of 20210G>A homozygosity is approximately one in 10,000. Double heterozygosity for the 20210G>A and factor V Leiden alleles occurs in approximately one in 1000 individuals in the general population and 2%-4.5% of persons with VTE;The prevalence of the G20210A in the general population is estimated to be 2.0%.     The prevalence of the G20210A substitution varies by ethnicity. It is most common in Europeans. the incidence is approximately 3.0% in southern Europeans, and 1.7% in northern Europeans. G20210A appears to be very rare in individuals of Asian and African descent.;<1 / 1 000 000        1
<1 / 1 000 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
1-5 / 10 000;1-9 / 1 000 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-5 / 10 000;1:8,000;1:100,000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-5 / 10 000;1-9 / 100 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-5 / 10 000;6-7:100,000.;<1 / 1 000 000;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1
1-9 / 1 000 000;1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1
<1 / 1 000 000;The prevalence of Joubert syndrome and related disorders has not been determined. Many authors use a range between 1:80,000 and 1:100,000, but this may represent an underestimate;1-9 / 1 000 000;1-9 / 100 000;Estimates range from 1:250,000 to 1:50,000.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
1-9 / 1 000 000;1 in 248,000 (combined Niemann-Pick A/B)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1
1-9 / 100 000;2:100,000-4:100,000.   The carrier frequency is 1:60-1:100.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1
1-9 / 100 000;Gastric cancer is the 4th most frequently diagnosed cancer and the 2nd leading cause of death from cancer, with an estimated 990000 new cases and 738000 deaths registered.;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1
Risk of 40%-80% for breast cancer  1:400;1-9 / 100 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1
1-5 / 10 000;1:10,000;~1:10,000 but HHT is suspected to be under-diagnosed due to variability in clinical symptoms;<1 / 1 000 000;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 1
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 100 000;1-9 / 1 000 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-9 / 100 000;1-9 / 1 000 000;1/35000;The prevalence of MEN 2 has been estimated at 1:35,000 [DeLellis et al 2004].;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1
1-9 / 1 000 000;1-9 / 100 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1
1-9 / 1 000 000;6-9 / 10 000;<1 / 1 000 000;1-9 / 100 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1
1-9 / 1 000 000;2:100.000;2.29 to 3.2 per 100,000 individuals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.;1-9 / 1 000 000;http://www.ncbi.nlm.nih.gov/books/NBK1247/;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                    1
1-9 / 100 000;Rett syndrome is an X linked condition that occurs in 1 in 10,000 to 1 in 15,000 live births.;The prevalence of AS is one in 12,000-20,000 population;The prevalence of AS is one in 12,000-20,000 population.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
1-9 / 1 000 000;1-5 / 10 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
Gastric cancer is the 4th most frequently diagnosed cancer and the 2nd leading cause of death from cancer, with an estimated 990000 new cases and 738000 deaths registered.;<1 / 1 000 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1
<1 / 1 000 000;1-9 / 1 000 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
Name: prevalence, dtype: int64
================
column 34: disease_mechanism
loss of function                                                                                                                                                                          29253
gain of function                                                                                                                                                                           1936
Disease mechanisms vary by gene.                                                                                                                                                            856
gain of function;loss of function                                                                                                                                                           198
Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function                                       190
loss of function;gain of function                                                                                                                                                           149
Affects gamma-sarcoglycan and also disrupts the integrity of the entire sarcoglycan complex.                                                                                                136
Other                                                                                                                                                                                       106
May be benign                                                                                                                                                                                63
unknown                                                                                                                                                                                      19
Disease mechanisms vary by gene.;loss of function                                                                                                                                             5
Dominant Negative                                                                                                                                                                             2
gain of function;Disease mechanisms vary by gene.                                                                                                                                             2
Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function;Disease mechanisms vary by gene.        1
Name: disease_mechanism, dtype: int64
================
column 35: origin
germline                                        256336
not provided                                      7618
unknown                                           6983
germline;unknown                                  5103
somatic                                           2518
germline;not provided                             2425
not provided;germline                             1026
de novo                                           1000
unknown;germline                                   851
inherited                                          538
maternal                                           344
germline;somatic                                   271
de novo;germline                                   252
germline;not provided;unknown                      250
not provided;unknown                               223
paternal                                           193
germline;inherited                                 184
germline;de novo                                   147
somatic;germline                                   133
germline;maternal                                  109
germline;paternal                                  100
germline;unknown;not provided                       51
not applicable                                      50
not provided;germline;unknown                       49
inherited;germline                                  42
germline;maternal;unknown                           41
not provided;unknown;germline                       36
de novo;unknown                                     32
de novo;germline;unknown                            30
germline;not applicable                             28
                                                 ...  
unknown;germline;not provided                        1
germline;de novo;inherited                           1
germline;maternal;unknown;not provided               1
not provided;germline;unknown;maternal               1
somatic;germline;maternal;paternal                   1
de novo;not provided;unknown                         1
not provided;de novo;germline;unknown                1
de novo;not provided                                 1
not-reported                                         1
germline;paternal;unknown;de novo                    1
germline;somatic;not provided;unknown                1
not provided;inherited;germline                      1
unknown;germline;de novo                             1
germline;somatic;paternal;unknown                    1
somatic;germline;not provided;unknown                1
unknown;maternal                                     1
unknown;germline;de novo;somatic                     1
germline;somatic;de novo                             1
germline;not provided;biparental                     1
germline;not applicable;not provided;unknown         1
germline;unknown;maternal;de novo;inherited          1
germline;de novo;unknown;somatic                     1
germline;not applicable;somatic                      1
inherited;maternal;not provided                      1
not provided;germline;de novo                        1
maternal;not provided;unknown                        1
not provided;paternal;germline                       1
germline;unknown;inherited                           1
germline;unknown;de novo;maternal                    1
germline;not provided;unknown;inherited              1
Name: origin, dtype: int64
